Related search

Translocation T(11;14) (Q13;q32) and Genomic Imbalances in Multi-Ethnic Multiple Myeloma Patients: A Malaysian Study

Hematology Reports
Hematology
2012English

MYEOV (Myeloma Overexpressed (In a Subset of T(11;14) Positive Multiple Myelomas))

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2012English

SOX11 Overexpression Is a Specific Marker for Mantle Cell Lymphoma and Correlates With T(11;14) Translocation, CCND1 Expression and an Adverse Prognosis

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2013English

Differential Tumorigenicity Between Epstein-Barr Virus Genome-Positive and Genome-Negative Cell Lines With T(11;14)(q13;q32) Derived From Mantle Cell Lymphoma.

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
1996English

Successful Venetoclax Salvage in the Setting of Refractory, Dialysis-Dependent Multiple Myeloma With T(11;14)

Haematologica
Hematology
2019English

ACE Insertion/Deletion Polymorphism (Rs4646994) Is Associated With the Increased Risk of Multiple Myeloma

Frontiers in Oncology
Cancer ResearchOncology
2019English

FOXM1 Is a Therapeutic Target in High-Risk Multiple Myeloma

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2015English

Survivin Promoter Polymorphism (-31 C/G): A Genetic Risk Factor for Oral Cancer

Asian Pacific Journal of Cancer Prevention
2019English

Real-World Data on Safety and Efficacy of Venetoclax-Based Regimens in Relapsed/Refractory T(11;14) Multiple Myeloma

British Journal of Haematology
Hematology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy